Surgical Glues Market

Surgical Glues Market Size Analysis

According to a research survey conducted by ChemView Consulting, in 2022, the Global Surgical Glues Market was worth US$ 2,358.8 Mn and is expected to grow at a CAGR of  8.6% over the forecast period. The market is expected to hit US$ 4,563.8 Mn by 2030 end.

Surgical glue, also known as a tissue adhesive or liquid stitches, is an addition to normal hemostasis procedures (staples or sutures), particularly in open surgical repair of major arteries. This surgical glue is used to seal big and small wounds, such as incisions.

One of the primary reasons driving the growth of the surgical glue market is the increase in the number of surgical operations performed worldwide. The growing demand for appropriate blood loss management in patients, as well as an increase in the number of traffic accidents and burn cases, are driving market expansion.

Market Dynamics

THE WIDE USE OF SURGICAL GLUE IN PHARMACEUTICAL APPLICATIONS IS DRIVING MARKET GROWTH.

The use of surgical glue in orthopedic, cardiovascular, ophthalmology, gastrointestinal, periodontal, and reconstructive procedures. Innovations in the surgical glue market are predicted to enhance biocompatibility with ongoing research and advancement.

Increasing awareness of the benefits of surgical glue, a considerable increase in the number of surgical operations worldwide, and a focus on enhancing the efficacy of new surgical glue are some key factors predicted to drive the growth of the surgical glue market.

HIGH PRODUCT COSTS HAMPER THE MARKET GROWTH

The high cost of the product and the time-consuming demand for clinical data for new product launches are projected to hamper market expansion. The surgical glue market is expected to be challenged by a shortage of reimbursements and experienced experts during the forecast period of 2022-2030.

Segment-Wise Analysis

Why is the natural/biological Surgical Glues product sector expected to have the greatest CAGR?

In 2021, the natural/biological Surgical glues sector held the biggest market share. The high percentage of natural/biological surgical glue can be attributed to the fact that sealants derived from natural polymers have superior biocompatibility, reduced immune response, and in vivo degradability compared to synthetic adhesive.

These are used to repair injured tissues and reinforce surgical wounds, thus replacing common suturing techniques.

Why is the tissue sealing segment expected to expand the fastest during the forecast period?

During the projection period, the tissue sealing sector is expected to expand the most in the market. It is due to the rising demand for tissue regeneration in situations of skin injuries or burns injuries, as well as the growing number of cosmetic procedures performed worldwide.

Which application segment is predicted to grow rapidly throughout the projection period?

During the projection period, the plastic surgery category is expected to expand the most in the market. It is due to the growing use of surgical glues in cosmetic and burns therapy operations. It is expected to rise further as the number of face cosmetic operations increases, as are incidences of skin injuries, the occurrence of burn injuries, and the number of breast cancer patients undergoing mastectomy and breast reconstruction treatments worldwide.

Which end-user segment is predicted to grow rapidly throughout the projection period?

In 2021, the hospital sector held the greatest share of the market. It is mostly due to an increase in the number of procedures performed worldwide due to the growing elderly population and various ailments.

Doctors are increasingly using them to limit blood loss and accomplish effective hemostasis and wound closure in trauma situations, injuries, or surgical operations. The inexpensive cost of these products and their ease of use, and decreased risk of problems provide substantial advantages, boosting market expansion.

Region-Wise Analysis

The regions analyzed for the market include North America, Europe, Latin America, Asia Pacific, Middle East, and Africa.

• North America dominated the surgical glue market in 2021 and is expected to continue to do so during the forecast period, owing to an increase in the number of surgeries, the presence of key players, the development of the healthcare sector, and the presence of new innovative surgical sealants and adhesives products. North America accounts for nearly 0% of the market share globally.
• Due to increased international care and investment in the area, Asia-Pacific is predicted to develop significantly from 2022 to 2030.

Competition Analysis

The surgical glue market is somewhat fragmented, with a few large-scale companies and local and regional players.

Companies have invested in R&D to provide products with enhanced features. Some of the key developments that have taken place in the Surgical Glues Market include:

• In November 2020, TISSIUM, a MedTech company, gained FDA clearance for its Investigational Device Exemption (IDE) application for its vascular sealant.
• In January 2020, Terumo Corporation developed AQUABRID, a revolutionary surgical sealant, in the European, Middle Eastern, and African markets.

A list of some of the key suppliers present in the market are:

• Johnson & Johnson
• Baxter International, Inc.
• Becton, Dickinson, and Company
• CryoLife, Inc.
• Cardinal Health, Inc.
• Braun Melsungen AG
• Integra Lifesciences Holdings Corporation
• Medline Industries, Inc.
• Adhezion Biomedical, LLC
• Tricol Biomedical, Inc.
• Vivostat A/S
• Advanced Medical Solutions Group plc
• Stryker Corporation
• CSL Limited
• Ocular Therapeutix, Inc.
• MicroVal
• GEM Srl
• Hemostasis, LLC
• Péters Surgical
• Tissuemed Ltd

Market Segments Covered in Report

By Product:

• Natural/Biological Surgical Glue
  • Natural/Biological Surgical Glue, By Type
    • Polypeptide/protein-based
      • Fibrin
      • Gelatin
      • Collagen
      • Albumin
    • Polysaccharide
      • Chitosan
      • Other Polysaccharide
  • Natural/Biological Surgical Glue, By Origin
    • Human-blood
    • Animal-based
• Synthetic & Semi-synthetic Surgical Glue
  • PEG Hydrogels
  • Cyanoacrylates
  • Urethane-based
  • Other Synthetic & semi-synthetic

By Indication:

• Hemostasis
• Tissue Sealing

By Application:

• Cardiovascular Surgery
• Plastic Surgery
• Liver & Spleen Lacerations
• Orthopedic Surgery
• Burn Bleeding
• Wound Management
• General Surgery
• Others

By End-User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Region and Country:

• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Netherlands, Norway, Russia, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Indonesia, Thailand, Vietnam, Australia & New Zealand, Rest of Asia-Pacific)
• Middle East (Saudi Arabia, Turkey, UAE, Rest of Middle East)
• Africa (South Africa, Nigeria, Egypt, Rest of Africa)

Global Surgical Glues Market 2022-2030: Report Coverage and Highlights

• Assessment of the historical and current market size (2017-2021), market projections (2022-2030), and its contribution to the parent market
• Key drivers, restraints, opportunities, and key emerging trends impacting market growth
• Predictions on critical supply, demand, and technological trends and changes in consumer behavior
• Value chain analysis (list of manufacturers, distributors, end-users, average profitability margins, etc.)
• Segment-wise, country-wise, and region-wise market analysis
• Competition mapping, market share analysis, key strategies adopted by top players, and competitive tactical intelligence
• Key product innovations and regulatory framework
• Covid-19 impact on the market and how to navigate
• Strategic market analysis and recommendations on crucial winning strategies